Advancing Chronic Tuberculosis Diagnostics Using Vision-Language Models: A Multi modal Framework for Precision Analysis
This provides a scalable solution for improving diagnostic consistency and accessibility in resource-constrained settings, though it is incremental as it builds on existing VLM methods for a specific medical domain.
The study tackled automated chronic tuberculosis screening by integrating chest X-ray images with clinical data using a vision-language model, achieving high precision and recall of 94% for detecting key pathologies and AUC scores above 0.93.
Background: This study proposes a Vision-Language Model (VLM) leveraging the SIGLIP encoder and Gemma-3b transformer decoder to enhance automated chronic tuberculosis (TB) screening. By integrating chest X-ray images with clinical data, the model addresses the challenges of manual interpretation, improving diagnostic consistency and accessibility, particularly in resource-constrained settings. Methods: The VLM architecture combines a Vision Transformer (ViT) for visual encoding and a transformer-based text encoder to process clinical context, such as patient histories and treatment records. Cross-modal attention mechanisms align radiographic features with textual information, while the Gemma-3b decoder generates comprehensive diagnostic reports. The model was pre-trained on 5 million paired medical images and texts and fine-tuned using 100,000 chronic TB-specific chest X-rays. Results: The model demonstrated high precision (94 percent) and recall (94 percent) for detecting key chronic TB pathologies, including fibrosis, calcified granulomas, and bronchiectasis. Area Under the Curve (AUC) scores exceeded 0.93, and Intersection over Union (IoU) values were above 0.91, validating its effectiveness in detecting and localizing TB-related abnormalities. Conclusion: The VLM offers a robust and scalable solution for automated chronic TB diagnosis, integrating radiographic and clinical data to deliver actionable and context-aware insights. Future work will address subtle pathologies and dataset biases to enhance the model's generalizability, ensuring equitable performance across diverse populations and healthcare settings.